Publicacións nas que colabora con MANUEL GUZMÁN PASTOR (66)

2023

  1. Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice

    Cell Death and Disease, Vol. 13, Núm. 7

  2. Prenatal THC exposure interferes with the neurodevelopmental role of endocannabinoid signaling

    Cannabis and the Developing Brain (Elsevier), pp. 259-282

2021

  1. Identification of bip as a cb1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain

    Journal of Neuroscience, Vol. 41, Núm. 38, pp. 7924-7941

  2. Δ9-Tetrahydrocannabinol promotes functional remyelination in the mouse brain

    British Journal of Pharmacology, Vol. 178, Núm. 20, pp. 4176-4192

  3. Δ9-Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo

    GLIA, Vol. 69, Núm. 3, pp. 532-545

2020

  1. Cannabinoid-induced motor dysfunction via autophagy inhibition

    Autophagy, Vol. 16, Núm. 12, pp. 2289-2291

  2. Endocannabinoid signalling in stem cells and cerebral organoids drives differentiation to deep layer projection neurons via CB1 receptors

    Development (Cambridge, England), Vol. 147, Núm. 24

  3. Inhibition of striatonigral autophagy as a link between cannabinoid intoxication and impairment of motor coordination

    eLife, Vol. 9, pp. 1-24

  4. Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure

    Neuropsychopharmacology, Vol. 45, Núm. 5, pp. 877-886

  5. Possible therapeutic applications of cannabis in the neuropsychopharmacology field

    European Neuropsychopharmacology, Vol. 36, pp. 217-234

2019

  1. Astroglial monoacylglycerol lipase controls mutant huntingtin-induced damage of striatal neurons

    Neuropharmacology, Vol. 150, pp. 134-144

  2. Contribution of altered endocannabinoid system to overactive mTORC1 signaling in focal cortical dysplasia

    Frontiers in Pharmacology, Vol. 9, Núm. JAN

  3. Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration

    Translational Neurodegeneration, Vol. 8, Núm. 1

2018

  1. Pathway-specific control of striatal neuron vulnerability by corticostriatal cannabinoid CB 1 receptors

    Cerebral Cortex, Vol. 28, Núm. 1, pp. 307-322

  2. Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum

    Neuropsychopharmacology, Vol. 43, Núm. 5, pp. 964-977

2017

  1. Cannabinoid type-2 receptor drives neurogenesis and improves functional outcome after stroke

    Stroke, Vol. 48, Núm. 1, pp. 204-212

  2. Loss of Cannabinoid CB1 Receptors Induces Cortical Migration Malformations and Increases Seizure Susceptibility

    Cerebral Cortex, Vol. 27, Núm. 11, pp. 5303-5317

2016

  1. MicroRNA let-7d is a target of cannabinoid CB 1 receptor and controls cannabinoid signaling

    Neuropharmacology, Vol. 108, pp. 345-352

  2. A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease

    Journal of Neurology, Vol. 263, Núm. 7, pp. 1390-1400